Hepatitis B Virus-Associated Hepatocellular Carcinoma by Giacomo Emanuele Maria Rizzo, Giuseppe Cabibbo, Antonio Craxì

Get full text

Transforming HCV Management by Graham Foster, Patrick Marcellin, Ira Jacobson, Heiner Wedemeyer, Christophe Hézode, Antonio Craxì

Get full text

Welcome to the Real World: Hepatitis C Virus Clinical Trials to Patient Realities by Heiner Wedemeyer, Ira Jacobson, Heiner Wedemeyer, Robert S. Brown, Jr., Antonio Craxí, Ira Jacobson

Get full text

Liver Function Test Abnormalities in Patients with Inflammatory Bowel Diseases: A Hospital-based Survey by Maria Cappello, Claudia Randazzo, Ivana Bravatà, Anna Licata, Sergio Peralta, Antonio Craxì, Piero Luigi Almasio

Get full text

Liver Function Test Abnormalities in Patients with Inflammatory Bowel Diseases: A Hospital-based Survey by Maria Cappello, Claudia Randazzo, Ivana Bravatà, Anna Licata, Sergio Peralta, Antonio Craxì, Piero Luigi Almasio

Get full text

Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey by Loreta A. Kondili, Maria Buti, Mar Riveiro-Barciela, Mojca Maticic, Francesco Negro, Thomas Berg, Antonio Craxì

Get full text

Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases. by Salvatore Petta, Fabio Salvatore Macaluso, Maria Rosa Barcellona, Calogero Cammà, Daniela Cabibi, Vito Di Marco, Antonio Craxì

Get full text

Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS. by Salvatore Petta, Alessandro Ciresi, Jessica Bianco, Vincenzo Geraci, Roberta Boemi, Luigi Galvano, Franco Magliozzo, Giovanni Merlino, Antonio Craxì, Carla Giordano

Get full text

Estimated prevalence of undiagnosed HCV infected individuals in Italy: A mathematical model by route of transmission and fibrosis progression by Loreta A. Kondili, Massimo Andreoni, Alfredo Alberti, Salvatore Lobello, Sergio Babudieri, Antonio Saverio Roscini, Rocco Merolla, Walter Marrocco, Antonio Craxì

Get full text

Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease. by Serena Pelusi, Salvatore Petta, Chiara Rosso, Vittorio Borroni, Anna Ludovica Fracanzani, Paola Dongiovanni, Antonio Craxi, Elisabetta Bugianesi, Silvia Fargion, Luca Valenti

Get full text

A systematic review on omics data (metagenomics, metatranscriptomics, and metabolomics) in the role of microbiome in gallbladder disease by Paola Di Carlo, Nicola Serra, Rosa Alduina, Riccardo Guarino, Antonio Craxì, Anna Giammanco, Teresa Fasciana, Antonio Cascio, Consolato M. Sergi, Consolato M. Sergi

Get full text

SARS-CoV-2 Viral Load, IFNλ Polymorphisms and the Course of COVID-19: An Observational Study by Emanuele Amodio, Rosaria Maria Pipitone, Stefania Grimaudo, Palmira Immordino, Carmelo Massimo Maida, Tullio Prestileo, Vincenzo Restivo, Fabio Tramuto, Francesco Vitale, Antonio Craxì, Alessandra Casuccio

Get full text

Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision Analysis by Giuseppe Cabibbo, Ciro Celsa, Marco Enea, Salvatore Battaglia, Giacomo Emanuele Maria Rizzo, Stefania Grimaudo, Domenica Matranga, Massimo Attanasio, Paolo Bruzzi, Antonio Craxì, Calogero Cammà

Get full text

Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma by Giuseppe Cabibbo, Ciro Celsa, Marco Enea, Salvatore Battaglia, Giacomo Emanuele Maria Rizzo, Anita Busacca, Domenica Matranga, Massimo Attanasio, Maria Reig, Antonio Craxì, Calogero Cammà

Get full text

NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis. by Anna Licata, Salvatore Corrao, Salvatore Petta, Chiara Genco, Mauro Cardillo, Vincenza Calvaruso, Giuseppe Cabibbo, Giuseppe Cabibbo, Fatima Massenti, Calogero Cammà, Giuseppe Licata, Antonio Craxì

Get full text

Performance of two HCV RNA assays during protease inhibitor-based triple therapy in patients with advanced liver fibrosis and cirrhosis. by Benjamin Maasoumy, Bela Hunyady, Vincenza Calvaruso, Mihály Makara, Johannes Vermehren, Attila Haragh, Simone Susser, Birgit Bremer, Gavin Cloherty, Michael P Manns, Antonio Craxì, Heiner Wedemeyer, Christoph Sarrazin

Get full text

Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease. by Salvatore Petta, Luca Miele, Elisabetta Bugianesi, Calogero Cammà, Chiara Rosso, Stefania Boccia, Daniela Cabibi, Vito Di Marco, Stefania Grimaudo, Antonio Grieco, Rosaria Maria Pipitone, Giulio Marchesini, Antonio Craxì

Get full text

An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1). by Tarik Asselah, Christophe Moreno, Christoph Sarrazin, Michael Gschwantler, Graham R Foster, Antonio Craxí, Peter Buggisch, Robert Ryan, Oliver Lenz, Jane Scott, Gino Van Dooren, Isabelle Lonjon-Domanec, Michael Schlag, Maria Buti

Get full text

Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development by Rosaria Maria Pipitone, Vincenza Calvaruso, Lorenza Di Marco, Francesca Di Salvo, Miriam Gaggianesi, Giulia Lupo, Rossella Zito, Claudia La Mantia, Matteo Ramazzotti, Salvatore Petta, Vito Di Marco, Antonio Craxì, Stefania Grimaudo

Get full text

Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease. by Salvatore Petta, Oreste Marrone, Daniele Torres, Maria Buttacavoli, Calogero Cammà, Vito Di Marco, Anna Licata, Anna Lo Bue, Gaspare Parrinello, Antonio Pinto, Adriana Salvaggio, Antonino Tuttolomondo, Antonio Craxì, Maria Rosaria Bonsignore

Get full text